BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 31378395)

  • 1. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Chappell LC; Bell JL; Smith A; Linsell L; Juszczak E; Dixon PH; Chambers J; Hunter R; Dorling J; Williamson C; Thornton JG;
    Lancet; 2019 Sep; 394(10201):849-860. PubMed ID: 31378395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
    Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial.
    Chappell LC; Gurung V; Seed PT; Chambers J; Williamson C; Thornton JG;
    BMJ; 2012 Jun; 344():e3799. PubMed ID: 22695903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Ovadia C; Seed PT; Sklavounos A; Geenes V; Di Ilio C; Chambers J; Kohari K; Bacq Y; Bozkurt N; Brun-Furrer R; Bull L; Estiú MC; Grymowicz M; Gunaydin B; Hague WM; Haslinger C; Hu Y; Kawakita T; Kebapcilar AG; Kebapcilar L; Kondrackienė J; Koster MPH; Kowalska-Kańka A; Kupčinskas L; Lee RH; Locatelli A; Macias RIR; Marschall HU; Oudijk MA; Raz Y; Rimon E; Shan D; Shao Y; Tribe R; Tripodi V; Yayla Abide C; Yenidede I; Thornton JG; Chappell LC; Williamson C
    Lancet; 2019 Mar; 393(10174):899-909. PubMed ID: 30773280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis.
    Ovadia C; Sajous J; Seed PT; Patel K; Williamson NJ; Attilakos G; Azzaroli F; Bacq Y; Batsry L; Broom K; Brun-Furrer R; Bull L; Chambers J; Cui Y; Ding M; Dixon PH; Estiú MC; Gardiner FW; Geenes V; Grymowicz M; Günaydin B; Hague WM; Haslinger C; Hu Y; Indraccolo U; Juusela A; Kane SC; Kebapcilar A; Kebapcilar L; Kohari K; Kondrackienė J; Koster MPH; Lee RH; Liu X; Locatelli A; Macias RIR; Madazli R; Majewska A; Maksym K; Marathe JA; Morton A; Oudijk MA; Öztekin D; Peek MJ; Shennan AH; Tribe RM; Tripodi V; Türk Özterlemez N; Vasavan T; Wong LFA; Yinon Y; Zhang Q; Zloto K; Marschall HU; Thornton J; Chappell LC; Williamson C
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):547-558. PubMed ID: 33915090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis.
    Roncaglia N; Locatelli A; Arreghini A; Assi F; Cameroni I; Pezzullo JC; Ghidini A
    BJOG; 2004 Jan; 111(1):17-21. PubMed ID: 14687046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
    Kawakita T; Parikh LI; Ramsey PS; Huang CC; Zeymo A; Fernandez M; Smith S; Iqbal SN
    Am J Obstet Gynecol; 2015 Oct; 213(4):570.e1-8. PubMed ID: 26071912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial.
    Fleminger J; Seed PT; Smith A; Juszczak E; Dixon PH; Chambers J; Dorling J; Williamson C; Thornton JG; Chappell LC
    BJOG; 2021 May; 128(6):1066-1075. PubMed ID: 33063439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T; Timonen S; Linden M; Suvitie P; Ekblad U
    BMC Gastroenterol; 2015 Jul; 15():92. PubMed ID: 26215400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M; Czajkowski K; Smolarczyk R
    Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo.
    Palma J; Reyes H; Ribalta J; Hernández I; Sandoval L; Almuna R; Liepins J; Lira F; Sedano M; Silva O; Tohá D; Silva JJ
    J Hepatol; 1997 Dec; 27(6):1022-8. PubMed ID: 9453428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Chappell LC; Brocklehurst P; Green ME; Hunter R; Hardy P; Juszczak E; Linsell L; Chiocchia V; Greenland M; Placzek A; Townend J; Marlow N; Sandall J; Shennan A;
    Lancet; 2019 Sep; 394(10204):1181-1190. PubMed ID: 31472930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A; Marschall HU; Lammert F; Mattsson LA
    Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011.
    ; Lee RH; Mara Greenberg ; Metz TD; Pettker CM
    Am J Obstet Gynecol; 2021 Feb; 224(2):B2-B9. PubMed ID: 33197417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X; Kong Y; Zhang F; Wang T; Yan J
    Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gradual dosing of ursodeoxycholic acid in mothers with intrahepatic cholestasis of pregnancy may improve composite neonatal outcome.
    Hamud A; Cohen MJ; Hochner-Celnikier D; Bar-Oz B; Ackerman Z
    Ann Hepatol; 2024; 29(3):101490. PubMed ID: 38403070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
    Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrahepatic cholestasis in pregnancy treated with ursodeoxycholic acid].
    Grønlund LA
    Ugeskr Laeger; 1999 Sep; 161(39):5433-4. PubMed ID: 10553357
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.